Non disponibileInduction of ATP Binding Cassette (ABC) proteins involved in the chloride transport has been proposed as possible mechanism of beneficial effects of azithromycin (AZM) in cystic fibrosis (CF) patients. This study focused on the effects of AZM on mRNA and protein expression of Multidrug Resistance-associated Protein 1 (MRP1) and Multidrug Resistance Protein 1 (MDR1) by real-time quantitative PCR, flow cytometry and gene reporter assays in two CF and two isogenic non-CF airway epithelial cell lines. We detected higher levels of MRP1 and lower levels of MDR1 mRNA in CF versus non-CF cells while both proteins were not differentially expressed. Following AZM treatment we found modest differences of MRP1 and MDR1 mRNA expre...
Lung damage in cystic fibrosis (CF) patients is determined by mucus accumulation, Pseudomonas aerugi...
Cystic Fibrosis (CF) is an autosomal recessive disease that affects thousands of individuals worldwi...
Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected w...
Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clin...
Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clin...
AbstractBackgroundBeneficial effects of azithromycin in cystic fibrosis (CF) have been reported, how...
Cystic fibrosis is a hereditary disease caused by a mutation in the Cystic Fibrosis Transmembrane co...
Azithromycin (AZM) has shown promising anti-inflammatory properties in chronic obstructive pulmonary...
Background: Beneficial effects of azithromycin in cystic fibrosis (CF) have been reported, however, ...
Several studies have reported clinical improvements in cystic fibrosis (CF) patients on macrolide an...
SummarySeveral studies have reported clinical improvements in cystic fibrosis (CF) patients on macro...
The macrolide antibiotic azithromycin improves lung function and prognosis among patients with cysti...
AbstractBackgroundAzithromycin treatment improves clinical parameters in patients with CF, and alter...
Virus-associated pulmonary exacerbations, often associated with rhinoviruses (RVs), contribute to cy...
Treatment with azm has been shown to improve pulmonary function in cystic fibrosis patients, as well...
Lung damage in cystic fibrosis (CF) patients is determined by mucus accumulation, Pseudomonas aerugi...
Cystic Fibrosis (CF) is an autosomal recessive disease that affects thousands of individuals worldwi...
Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected w...
Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clin...
Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clin...
AbstractBackgroundBeneficial effects of azithromycin in cystic fibrosis (CF) have been reported, how...
Cystic fibrosis is a hereditary disease caused by a mutation in the Cystic Fibrosis Transmembrane co...
Azithromycin (AZM) has shown promising anti-inflammatory properties in chronic obstructive pulmonary...
Background: Beneficial effects of azithromycin in cystic fibrosis (CF) have been reported, however, ...
Several studies have reported clinical improvements in cystic fibrosis (CF) patients on macrolide an...
SummarySeveral studies have reported clinical improvements in cystic fibrosis (CF) patients on macro...
The macrolide antibiotic azithromycin improves lung function and prognosis among patients with cysti...
AbstractBackgroundAzithromycin treatment improves clinical parameters in patients with CF, and alter...
Virus-associated pulmonary exacerbations, often associated with rhinoviruses (RVs), contribute to cy...
Treatment with azm has been shown to improve pulmonary function in cystic fibrosis patients, as well...
Lung damage in cystic fibrosis (CF) patients is determined by mucus accumulation, Pseudomonas aerugi...
Cystic Fibrosis (CF) is an autosomal recessive disease that affects thousands of individuals worldwi...
Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected w...